Phibro: 3 Key Takeaways for Long-Term Investors

Phibro reported Q1 FY2027 net sales of $386.8 million, up 6% year-over-year, with strong growth in higher-margin segments like Mineral Nutrition (+17%) and Performance Products (+16%). However, poultry market softness pressured short-term demand as producer margins tightened. Management prioritizes reducing excess inventory to improve free cash flow and pay down debt, while expecting protein producer margins to recover as feed costs decline.